DE10393402T8 - Mittel und Toilettenartikel- oder pharmazeutische Zusammensetzung zum Beschleunigen der Aufnahme von basischen Aminosäuren in Zellen - Google Patents

Mittel und Toilettenartikel- oder pharmazeutische Zusammensetzung zum Beschleunigen der Aufnahme von basischen Aminosäuren in Zellen Download PDF

Info

Publication number
DE10393402T8
DE10393402T8 DE2003193402 DE10393402T DE10393402T8 DE 10393402 T8 DE10393402 T8 DE 10393402T8 DE 2003193402 DE2003193402 DE 2003193402 DE 10393402 T DE10393402 T DE 10393402T DE 10393402 T8 DE10393402 T8 DE 10393402T8
Authority
DE
Germany
Prior art keywords
toiletry
cells
agent
amino acids
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE2003193402
Other languages
English (en)
Other versions
DE10393402T5 (de
Inventor
Kazuko Kawasaki Ogasahara
Yoshinobu Kawasaki Takino
Kazutami Kawasaki Sakamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of DE10393402T5 publication Critical patent/DE10393402T5/de
Application granted granted Critical
Publication of DE10393402T8 publication Critical patent/DE10393402T8/de
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Birds (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
DE2003193402 2002-06-19 2003-06-17 Mittel und Toilettenartikel- oder pharmazeutische Zusammensetzung zum Beschleunigen der Aufnahme von basischen Aminosäuren in Zellen Expired - Fee Related DE10393402T8 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002177911A JP4851046B2 (ja) 2002-06-19 2002-06-19 細胞への塩基性アミノ酸取り込み促進剤および医薬組成物
JP2002-177911 2002-06-19
PCT/JP2003/007698 WO2004000245A1 (ja) 2002-06-19 2003-06-17 細胞への塩基性アミノ酸取り込み促進剤および化粧料もしくは医薬組成物

Publications (2)

Publication Number Publication Date
DE10393402T5 DE10393402T5 (de) 2005-09-29
DE10393402T8 true DE10393402T8 (de) 2006-03-30

Family

ID=29996498

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2003193402 Expired - Fee Related DE10393402T8 (de) 2002-06-19 2003-06-17 Mittel und Toilettenartikel- oder pharmazeutische Zusammensetzung zum Beschleunigen der Aufnahme von basischen Aminosäuren in Zellen

Country Status (4)

Country Link
JP (1) JP4851046B2 (de)
AU (1) AU2003244241A1 (de)
DE (1) DE10393402T8 (de)
WO (1) WO2004000245A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7977379B2 (en) 2002-05-15 2011-07-12 Bhn Co., Ltd. Method for angiogenesis inhibition or immunostimulation
JP4826696B2 (ja) * 2003-04-07 2011-11-30 ビーエイチエヌ株式会社 血管新生阻害剤
JP4990132B2 (ja) * 2005-04-28 2012-08-01 太陽化学株式会社 含水食品
JP5294149B2 (ja) * 2006-09-29 2013-09-18 味の素株式会社 グルタミン含有血流増加用組成物
FR2916351B1 (fr) * 2007-05-22 2012-12-07 Galderma Res & Dev Composition pharmaceutique comprenant au moins deux composes choisis parmi l'acide pyrrolidone-5-carboxylique, la citrulline, l'arginine et l'asparagine et leur utilisation dans le traitement de la dermatite atopique
CA2815636C (en) 2010-11-12 2016-12-06 Colgate-Palmolive Company Oral care product and methods of use and manufacture thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS533539A (en) * 1976-06-25 1978-01-13 Ajinomoto Co Inc First liquid for cold permanent wave treatment
US4837019A (en) * 1986-08-11 1989-06-06 Charles Of The Ritz Group Ltd. Skin treatment composition and method for treating burned skin
JP3525233B2 (ja) * 1995-09-20 2004-05-10 味の素株式会社 化粧料
JP4681132B2 (ja) * 2001-01-29 2011-05-11 味の素株式会社 一酸化窒素合成酵素産生促進剤および化粧料若しくは医薬組成物

Also Published As

Publication number Publication date
DE10393402T5 (de) 2005-09-29
WO2004000245A1 (ja) 2003-12-31
JP4851046B2 (ja) 2012-01-11
AU2003244241A1 (en) 2004-01-06
JP2004018483A (ja) 2004-01-22

Similar Documents

Publication Publication Date Title
EP1578922A4 (de) Replikinpeptide bei der schnellen replikation von gliomzellen und bei grippeepidemien
HK1152863A1 (en) Pharmaceutical compositions comprising botulinum neurotoxin for use in medicine and cosmetics
DE60019628D1 (de) Bicyclische aminosäuren als pharmazeutische mittel
DE60321450D1 (de) Pharmazeutische zubereitungen von antineoplastischen wirkstoffen, insbesondere temozolomid, verfahren zu ihrer herstellung und deren verwendung
IL222879A (en) Peptides and their use in the treatment and diagnosis of diseases and pharmaceutical preparations containing them
DE60326730D1 (de) Verfahren zur proteinverabreichung in zellen
ATE381335T1 (de) 2-cyanopyrrolopyrimidine und deren pharmazeutische verwendung
AR028426A1 (es) Una composicion farmaceutica y procedimiento de tratamiento de enfermedades de disfunsion cognitiva en un mamifero
ATE401800T1 (de) Hochintensive süssstoffzusammensetzung und deren abgabe
ATE517081T1 (de) Hydroxamsäureester und deren pharmazeutische verwendung
DE69941996D1 (de) Pharmazeutische zusammenstellung zur verwendung in notbehandlungen und dessen herstellungsverfahren
DE69840932D1 (de) Zusammensetzungen und verfahren zur verstärkung der verabreichung von therapeutischen mitteln in zellen
EP1667704A4 (de) Mehrarmige peptidverbindungen, verfahren zu ihrer herstellung und verwendung in der therapie
DE10393402T8 (de) Mittel und Toilettenartikel- oder pharmazeutische Zusammensetzung zum Beschleunigen der Aufnahme von basischen Aminosäuren in Zellen
PL361518A1 (en) Application of substance and pharmaceutical composition
DE60330255D1 (de) Thermoplastharzzusammensetzung und formkörper daraus
DK1467750T3 (da) Orodispergerbar farmaceutisk sammensætning omfattende perindopril
DE60329614D1 (de) Polymerzusammensetzung sowie diese enthaltende darreichungsformen
EE05030B1 (et) Meetod N-[(S)-1-karboksbutl]-(S)-alaniini estrite snteesimiseks ja nende kasutamine perindopriili snteesis
FR2846327B1 (fr) Derives de n-benzodioxolyl, n-benzodioxanyl et n-benzodioxepinyl arylcarboxamides utilisables dans le traitement de dyslipidemies et compositions pharmaceutiques les contenant.
PL361364A1 (en) Peptide and pharmaceutical composition as well as their therapeutic applications
MXPA05009666A (es) Uso de polimeros de proteina de secuencia de repeticion en composiciones para cuidado personal.
DK1482967T3 (da) Farmaceutiske og kosmetiske sammensætninger omfattende plgf-1
ATE456573T1 (de) Nmb0928-protein und dessen verwendung in pharmazeutischen formulierungen
FR2857667B1 (fr) Nouveaux conjugues peptidiques utiles dans le traitement preventif et curatif de l'alopecie

Legal Events

Date Code Title Description
8181 Inventor (new situation)

Inventor name: OGASAHARA, KAZUKO, KAWASAKI, KANAGAWA, JP

Inventor name: SAKAMOTO, KAZUTAMI, KAWASAKI, KANAGAWA, JP

Inventor name: TAKINO, YOSHINOBU, KAWASAKI, KANAGAWA, JP

8696 Reprint of defective front page
8110 Request for examination paragraph 44
R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee

Effective date: 20140101